Sigma Planning Corp’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Sigma Planning Corp’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,775	Closed	-$385K	–	1317
2023 Q2	$385K	Sell	3,775 -2,545	-40%	-$241K	0.01%	842
2023 Q1	$575K	Sell	6,320 -2,975	-32%	-$175K	0.02%	744
2022 Q4	$353K	Sell	9,295 -92	-1%	-$3.17K	0.01%	904
2022 Q3	$236K	Sell	9,387 -928	-9%	-$25.7K	0.01%	1047
2022 Q2	$313K	Buy	+10,315	New	+$308K	0.01%	969
2021 Q4	–	Sell	-6,544	Closed	-$658K	–	1497
2021 Q3	$658K	Buy	6,544 +184	+3%	+$21.6K	0.02%	700
2021 Q2	$900K	Buy	6,360 +2,015	+46%	+$228K	0.03%	594
2021 Q1	$433K	Buy	4,345 +630	+17%	+$73.5K	0.01%	824
2020 Q4	$459K	Buy	+3,715	New	+$488K	0.02%	728

Other funds holding RETA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sigma Planning Corp's RETA Position: Q3 2023 in Review

Sigma Planning Corp sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2023, closing a stake of 3,775 shares — an estimated $385K sold.

Sigma Planning Corp first reported a position in RETA in Q4 2020 and held it in 9 quarters. The position peaked at $900K in Q2 2021. 2 funds tracked by Wall St. Rank hold RETA as of Q3 2023.

Sigma Planning Corp reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Sigma Planning Corp sold 3,775 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2023, an estimated $385K.
Sigma Planning Corp first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q4 2020 and held it in 9 quarters.
Sigma Planning Corp's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $900K in Q2 2021.
2 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2023.

Based on Sigma Planning Corp's 13F filing for Q3 2023, filed 6 Nov 2023.